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Abstract: Marine sponge Hymeniacidon sp. was collected from coastal waters of the East 
China  Sea  to  isolate  symbiotic  microorganisms.  The  resulting  sponge-associated 
actinomycete, Streptomyces carnosus strain AZS17, was cultivated in a 20 L volume of 
medium for production of bioactive secondary metabolites. Bioassay-guided isolation and 
purification  by  varied  chromatographic  methods  yielded  two  new  compounds  of 
kijanimicin  derivatives,  AS7-2  and  AS9-12.  Their  structures  were  elucidated  by 
spectroscopy and comparison with literatures. Results showed these two compounds were 
structurally similar to the previously reported compounds lobophorin A and B, yet differed 
in specific bond forms, stereochemistry and optical activities. The two novel compounds 
were  named  lobophorin  C  and  D.  In  vitro  cytotoxicity  investigation  by  MTT  assay 
indicated their selective activities. Lobophorin C displayed potent cytotoxic activity against 
the human liver cancer cell line 7402, while lobophorin D showed significant inhibitory 
effect on human breast cancer cells MDA-MB 435.  
Keywords: marine sponge; actinomycete; lobophorin C and D; cytotoxic activity 
 
OPEN ACCESS Mar. Drugs 2011, 9  
 
 
360 
1. Introduction  
Sponges (Porifera) remain the most important phylum in the field of marine drugs discovery, since 
they  produce  a  great  number  of  novel  natural  products  with  a  variety  of  potent  pharmacological 
activities. Nevertheless, the transformation of marine sponge-derived active compounds into drugs has 
been hindered by supply limitation. It is well known that sponges are hosts for a large amount of 
microorganisms, demonstrating interactions such as epibiotic, symbiotic and parasitic relationships, etc. 
Symbiotic functions that have been attributed to marine sponge microbial associates include nutrient 
acquisition and secondary metabolite production [1]. The various secondary metabolites synthesized 
by microbial associates inhabiting marine sponges also possess good bioactivities in many studies [2–6]. 
In recent years, microbial diversity in the marine environment, particularly marine sponge-associated 
microorganisms, have become a significant source of new lead compounds for marine drugs with vast 
biotechnological potential. 
During the course of our investigation for bioactive natural products from marine sponge-associated 
microorganisms, we have isolated some known metabolites from marine sponge-derived fungi. In this 
paper, we report the isolation and characterization of two new compounds of kijanimicin derivatives 
from  the  fermentation  broth  of  a  variant  strain  of  Streptomyces  carnosus  associated  with  marine 
sponges Hymeniacidon sp. The in vitro cytotoxic activities were detected against two human cancer 
cell lines. This is the first report of bioactive metabolites derived from Streptomyces associated with 
marine sponges of the genus Hymeniacidon according to the current review of Thomas [7]. 
2. Results and Discussion 
Compound  1  (lobophorin  C)  was  obtained  as  a  white  amorphous  powder,  soluble  in  dimethyl 
sulphoxide (DMSO) and methanol. It gave the [M + Na]
+ ion at m/z 1209 in the ESI-MS, indicating a 
molecular weight of 1186. HR-ESI-MS analysis displayed the [M + Na]
+ signal at m/z 1209.5958 
(calculated 1209.5934). Element analysis revealed the compound consists of N (2.019%), C (54.11%), 
H (7.219%), O (36.65%). Thus, the molecular formula of AS7-2 was established to be C61H90N2O21 
based  on  HR-ESIMS, 
1H  and 
13C  NMR  data  (Table  1)  and  element  analysis,  with  18  sites  of 
unsaturation.  The  IR  spectrum  of  1  showed  bands  characteristic  of  hydroxyl  (3432  cm
−1),  ester 
carbonyl (1721 cm
−1) groups and olefinic bonds (1631 cm
−1). UV spectrum exhibited the maximum 
absorption bands at 267 and 241 nm. The 
1H-NMR spectrum demonstrated the presence of eleven 
methyl protons, two methoxyl protons (δ 3.59, s; 3.26, s), one anomeric proton and a NH proton signal 
(δ 7.40). The 
13C-NMR spectrum of 1 (Table 1) revealed signals for 61 carbons. 
13C-NMR and various 
DEPT  spectra  allowed  the  assignments  of  the  61  carbon  signals  to  eleven  methyl,  two  methoxyl  
(δ 55.7, 51.9), eight methylene and 29 methine and eleven quaternary carbon atoms. Among them, four 
anomeric carbons (δ 99.08, 97.63, 97.34, 91.20) suggested the presence of four sugar residues. The 
correlation of the adjoining proton resonances was investigated by 
1H-
1H COSY, showing the HH 
connectivities as: H15-H16-H17, H19-H20-H21, H24-H23-H33, H13-H12-H11-H10-H9-H8-H29, H8-H7-H6 and 
H10-H5-H6-H28 (Figure 1). The correlation of neighboring protons in A-ring sugar moiety was found to 
be H1A-H2A-H3A-H4A-H5A-H6A, similar proton connectivities in B-ring and C-ring sugar moieties can be 
derived from the cross peaks of the 
1H-
1H COSY spectrum. In the HMBC experiment, the following Mar. Drugs 2011, 9  
 
 
361 
key  correlations  were  observed  in  the  aglycone  part  of  compound  1:  H-5  to  C-7,  C-6,  C-4, 
C-28; H-7 to C-29, C-28; H-8 to C-29; H-13 to C-27, C-14, C-12, C-11, C-4; H-21 to C-19, C-20, C-23, 
C-32; H-24 to C-33, C-25, C-22, C-20; H-27 to C-5, C-4, C-3; H-28 to C-7, C-6, C-5; H-29 to C-9,  
C-8, C-7; H-30 to C-15, C-14, C-13; H-32 to C-23, C-22, C-21; H-33 to C-24, C-23, C-22 (Table 1 
and Figure 1). HMBC correlations were detected within the sugar units as: H-6D with C-5D, C-4D; H-5C 
with C-6C, C-4C; H-4C with C-5C, C-3C, C-6C; H-2B with C-3B; H-3B with C-1B; H-5A with C-6A, C-1A; 
H-4A with C-6A; H-1A with C-3A, C-5A (Table 1 and Figure 1). The points of attachment for the sugar 
moieties of ring A and ring D to the C-9 and C-17 sites of the aglycone, respectively, were determined 
via the long-range correlations of H-1A to C-9, H-1D to C-17, as well as H-17 to C-1D.  
Table 1. NMR data of compound 1 (δ in ppm, J in Hz). 
No. 
13C 
1H  HMBC 
1H-
1H COSY  NOESY 
1  173.6 C         
2  96.5 C         
3  197.4 C         
4  50.4 C         
5  43.4 CH  2.00(m,overlap *)  C-28,27,7,6,4  H-6,10  H-28,9 
6  31.1 CH  1.38(m,overlap)  C-28  H-28  H-27,10,8 
7  41.7 CH2  1.51(m,overlap), 
1.38(m,overlap) 
C-29,28  H-8,6   
8  34.1 CH  2.09(m,overlap)  C-29  H-29  H-10,6 
9  84.0 CH  3.29(m,overlap)  C-29  H-10,8  H-29,5 
10  38.5 CH  1.89(m,overlap)    H-11,9,5  H-27,8,6 
11  125.2 CH  5.65(d,10.5)  C-13  H-12   
12  128.0 CH  5.28(m,overlap)  C-13  H-13,11   
13  50.1 CH  3.71(m,overlap)  C-27,14,12,11,4  H-12  H-27 
14  136.0 C         
15  121.4 CH  5.06(brs)  C-13  H-16   
16  35.1 CH2  2.06(m,overlap)  C-17  H-17   
17  79.1 CH  4.07(d,5.6)  C: 31,19, D-1  H-16   
18  135.1 C         
19  120.4 CH  5.02(d,8)  C-31,21  H-20   
20  39.5 CH  3.21(d,8)  C-21  H-21,19   
21  123.3 CH  5.31(s)  C-32,23,20,19  H-20   
22  140.6 C         
23  27.1 CH  2.45(m,overlap)  C-33,22  H-33,24   
24  35.5 CH2  2.48(m,overlap) 
1.43(m,overlap) 
C-33,25,22,20  H-23   
25  91.1 C         
26  199.9 C         
27  14.8 CH3  1.38(s)  C-5,4,3    H-13,10,6 
28  22.3 CH3  0.55(d,4.4)  C-7,6,5  H-6  H-29,5 
29  13.9 CH3  1.01(d,5.6)  C-9,8,7  H-8  H-28,9 
30  15.0 CH3  1.41(s)  C-15,14,13     
31  14.0 CH3  1.26(s)       Mar. Drugs 2011, 9  
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Table 1. Cont. 
32  63.5 CH2  4.02(m,overlap) 
3.88(m,overlap) 
C-23,22,21  OH-4.60   
33  19.8 CH3  1.16(d,5.6)  C-24,23,22  H-23   
A-2  29.2 CH2  2.21(brd,12) 
1.65(brd,12) 
  H: A-2, A-1   
A-3  66.9 CH  3.85(m,overlap)  C: A-1  H: A-4, A-2   
A-4  70.8 CH  3.15(m,overlap)  C: A-6  H: A-5, A-3, OH4.79   
A-5  64.0 CH  3.96(m,overlap)  C: A-6, A-1  H: A-6, A-4   
A-6  17.4 CH3  1.09(d,5.2)    H: A-5   
B-1  91.2 CH  5.05(brs)    H: B-2   
B-2  35.2 CH2  1.85(m,overlap)  C: B-3  H: B-3, B-1   
B-3  66.2 CH  3.91(brs)  C: B-1  H: B-2, B-4   
B-4  81.4 CH  3.14(m,overlap)  C: C-1  H: B-3, B-5   
B-5  61.9 CH  3.96(m,overlap)  C: B-1  H: B-4, B-6   
B-6  17.9 CH3  1.10(d,5.2)    H: B-5   
C-1  99.1 CH  4.82(d,7.6)  C: C-5, C-2, B-4  H: C-2   
C-2  37.8 CH2  1.54(m,overlap)    H: C-3, C-1   
C-3  61.9 CH  4.15(brs)    H: C-4, C-2, OH4.60   
C-4  82.1 CH  2.76(dd,9.5,2.5)  C: C-6, C-5, C-3,  
C-4OCH3 
H: C-5, C-3   
C-5  67.5 CH  3.69(m,overlap)  C: C-6, C-4  H: C-6, C-4   
C-6  18.2 CH3  1.13(d,5.2)    H: C-5   
C-4OCH3  55.7 CH3  3.26(s)  C: C-4     
D-1  97.6 CH  4.36(d,7.6)  C: 17, D-5, D-2  H: D-2   
D-2  30.8 CH2  2.27(m,overlap) 
2.08(m,overlap) 
C: D-3CH3  H: D-2, D-1   
D-3  82.0 C         
D-4  53.1 CH  4.24(d,8.4)  C: D-6,D-5,  
D-4C=O, D-3CH3 
H: D-5, NH   
D-5  68.6 CH  3.43(m,overlap)  C: D-6  H: D-6, D-4   
D-6  16.8 CH3  1.01(d,5.2)  C: D-5, D-4  H: D-5   
D-3CH3  24.9 CH3  1.43(s)  C: D-3, D-2     
D-4C=O  157.7 C         
D-4OCH3  51.9 CH3  3.59(s)  C: D-4     
The spectra were recorded in DMSO-d6 at 500 MHz for 
1H and 125 MHz for 
13C; * Due to signal 
overlapping, coupling constants could not be determined. 
The NOESY spectrum provided information regarding the relative configuration of the compound 1. 
Key NOE interactions were recorded between H-5 (δ 2.00) and H-9 (δ 3.29), H-5 and H-28 (δ 0.55) as 
shown in Figure 2, implying H-9, H-5 and the methyl group in site 28 (H-28) were close to each other 
with  same  orientation.  Also,  NOE  interaction  can  be  observed  between  H-28  and  H-29  (δ  1.01), 
indicating the orientation of the CH3 group in site 28 was identical with the CH3 group in site 29. 
Accordingly, they should be in the same side of the aglycone plane. 
 Mar. Drugs 2011, 9  
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Figure 1. The key 
1H-
1HCOSY and HMBC correlations of compound 1. 
 
Figure 2. The key NOESY correlations of compound 1. 
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The structure of compound 1 was very similar to the compound lobophorin B, derived from an 
unidentified  actinomycete  strain  CNC-837  isolated  from  the  surface  of  the  Caribbean  brown  alga 
Lobophora variegata [8]. Both of them were derivatives of the terrestrial antibiotic kijanimicin [9], with 
one less sugar moiety than kijanimicin and contained one 2,6-dideoxy-4-O-methyl-l-ribo-hexopyranose 
and two 2,6-dideoxy-l-ribo-hexopyranose in their sugar units. By comparison of their spectral data, 
compound 1 is distinctly different from the known lobophorin B in these aspects: Firstly, a –OH group 
and a C=O group linked to the sites of C-3 and C-26 in compound 1 respectively, while a C=O and a  
–OH attached to these positions in lobophorin B, respectively. Consequently, the unsaturated double 
bond between C-3 and C-2 and the saturated single bond between C-2 and C-26 in compound 1 were 
substituted  by  a  saturated  bond  and  an  unsaturated  double  bond  in  lobophorin  B,  respectively, 
exhibiting  transformations  between  enol  and  ketone  forms.  These  changes  can  be  confirmed  by 
chemical shifts in the corresponding positions (Table 1). Secondly, the two CH3 groups in C-28 and  
C-29, which were in opposite orientation in lobophorin B, were in the same side in compound 1 by 
NOE analysis. Besides, the optical rotation of compound 1 was −150.9° , in contrast with +104°  of 
lobophorin B when measured in same condition. To sum up, the structure of compound 1, which 
derived from a marine sponge symbiotic actinomycete, was not identical to the previously reported 
compound  lobophorin  B  due  to  mutual  enol  and  ketone  transformations  in  local  groups,  relative 
stereochemistry and optical activities. Therefore, compound 1 was named lobophorin C. Its structure is 
shown in Figure 3. 
Compound 2 (lobophorin D) was obtained as a white amorphous powder like lobophorin C (1). The 
molecular weight  was  deduced as  1156 from  the pseudomolecular ions [M + H]
+ at  m/z  1157 in 
positive  ESI-MS  and  [M  −  H]
−  at  m/z  1155  in  negative  ESI-MS.  Element  analysis  showed  the 
compound consist of N (2.049%), C (50.10%), H (7.103%), O (40.75%). The molecular formula of 
compound 2 was determined as C61H92N2O19 based on ESI-MS, 
1H and 
13C NMR spectra and element 
constitution  analysis. 
13C  NMR  and  DEPT  spectra  displayed  11  CH3  carbon  signals,  2  –OCH3 
carbons；8 CH2 carbons and 29 CH carbons. HSQC spectrum revealed 11 quaternary carbons without 
protons attachment. Compound 2 resembled lobophorin C (1) in signals assignments by 
1H-
1HCOSY 
coupled with HMBC spectra. Both showed great structural similarities except that the substitute group 
in C-3 of sugar ring D was –NH2 in compound 2 instead of –NO2 in lobophorin C (1). Compound 2 
exhibited almost identical structure with the published compound lobophorin A, except that a hydroxyl 
group and a carbonyl group linked to the sites of C-3 and C-26 in the aglycone part of compound 2, 
respectively, deduced by its spectral NMR data. In addition, both the methyl groups of C-29 and C-28 
in compound 2 were in the same spatial orientation, and compound 2 displayed an optical rotation of 
−138.4° while −175° was observed for lobophorin A. Hence, compound 2 was named lobophorin D 
(Figure 3). 
The cytotoxicity of compounds 1 and 2  were tested in vitro  against a  human liver cancer cell 
line 7402  and  a  human  breast  cancer  cell  line  MDA-MB  435.  The  results  showed  compound  1 
demonstrated a strong cytotoxic activity while compound 2 was inactive against the cell proliferation 
of 7402 hepatoma cells, with IC50 values of 0.6 μg/mL and 723.1 μg/mL, respectively. On the contrary, 
compound  2  displayed  a  good  inhibitory  effect  on  the  growth  of  human  breast  cancer  cells  
MDA-MB 435 with an IC50 value of 7.5 μM, in contrast to the negligible activity of 61.8 μM for 
compound  1.  Apoptosis  of  the  breast  adenocarcinoma  cells  can  be  observed  with  increasing Mar. Drugs 2011, 9  
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concentrations of compound 2 (Figure 4). Compounds 1 and 2 seemed to have selective cytotoxicity 
for these cancer cell lines. Though as derivatives of kijanimicin with similar structures, compounds 1 
and  2,  in  contrast  with  lobophorin  A  and  B  demonstrated  different  bioactivities.  The  previously 
reported lobophorins A and B did not exhibit significant antibiotic properties, whereas they showed 
potent  anti-inflammatory  activities.  It  is  suggested  that  the  distinction  of  bioactivities  was  likely 
attributed to the differences of stereochemistry of the two groups of compounds and their optical 
activities, as well as the slight modification of specific bonds. The mechanism of cytotoxic selectivity 
of compounds 1 and 2 to various cancer cell lines needs to be further investigated. 
Figure 3. The structures of lobophorin C (1) and D (2). 
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Figure  4.  Effect  of  compound  2  on  the  growth  of  the  human  breast  cancer  cell  line  
MDA-MB 435 under different concentrations. 
 
100×          200×  
3. Experimental Section  
3.1. General Procedures 
Optical rotations were measured on a Horiba High Sensitivity Polarimeter SEPA-300. UV and IR 
spectra were measured on a Shimadzu UV-2501PC spectrophotometer and a Bruker VECTOR 22 FT-IR 
spectrophotometer, respectively. NMR spectroscopic data were recorded on a Varian INOVA 500NB 
NMR spectrometer. ESIMS and HR-ESIMS spectra were measured on a Thremo LCQ DECA XP LC Mar. Drugs 2011, 9  
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mass spectrometer and a Q-TOF Ultima Global GAA076 LC mass spectrometer respectively. Element 
analysis used an Elementar Vario EL CHNSO elemental analyzer. 
3.2. Strain Isolation and Fermentation 
Actinomycete  strain  AZS  17  was  isolated  as  an  endosymbiotic  microorganism  from  a  marine 
sponge collected from the intertidal zone of Qingbang island of Zhoushan Archipelago in the East 
China Sea. The sponge was identified as Hymeniacidon sp.—which is likely to be a new species within 
the  genus  Hymeniacidon—by  Professor  Jinhe  Li,  Institute  of  Oceanology,  Chinese  Academy  of 
Sciences.  The  actinomycetic strain  was  preliminary  identified as  a Streptomyces  species based  on 
morphology  observation  and  physio-biochemical  characteristics.  Molecular  sequencing  of  the  16S 
rRNA gene (Accession number FJ999670) revealed it was a variant species of Streptomyces carnosus.  
Strain AZS 17 cultivated on Gause’s I slant medium was streaked onto a agar plate containing a 
half seawater-based medium (malt extract 10 g, yeast extract 4 g, glucose 4 g and agar 18 g dissolved 
in 0.5 L artificial seawater and 0.5 L tap water for sterilization and solidification) and cultured at 28 °C  
for 4 days in an incubator. The acquired seed culture was cut into small pieces before a small piece was 
inoculated into a 1000 mL Erlenmeyer flask containing 250 mL of the above culture medium without 
agar in a total volume of 20 L, subsequently incubated in a shaker under 28 °C , 110 rpm for 5 days. 
3.3. Extraction and Isolation 
The fermented culture (20 L) was filtered through kieselguhr (Sinopharm Reagent, Shanghai, China) 
to separate the mycelia. The filtrate was extracted with ethyl acetate three times, while the mycelia 
were treated under ultrasonication before extraction by EtOAc. The combined extracts were evaporated 
in vacuo at 37 °C  to yield 7.89 g brown oily residue. This crude extract was chromatographed on a silica 
gel column using a stepwise gradient of petroleum ether–EtOAc–MeOH to afford nine fractions. Brine 
shrimp bioassay-guided fractionation excludes others to target fr.7 and fr.9. Fr.7 was subjected to 
Sephadex  LH-20  column  chromatography  eluting  with  CHCl2–MeOH  (1:1)  to  obtain  4  fractions.  
Fr.7-2 was selected to reverse phase column chromatography on a YMC (YMC Co. Ltd., Japan) ODS 
column.  Preparative  thin  layer  chromatography  with  Merck  precoated  TLC  plate  and  repeated 
Sephadex  LH-20  column  chromatography  purification  yielded  compound  1  (51.3  mg).  Similar 
methods were applied to the isolation of Fr.9 and eventually obtained compound 2 (42.6 mg). 
3.4. Cytotoxicity Assays and Observation 
Human liver cancer cells 7402 were obtained from the Cell Bank of Type Culture Collection of 
Shanghai Institute of Cell Biology, the Chinese Academy of Sciences. Human breast adenocarcinoma 
cells MDA-MB 435 were provided by Cancer Research Centre, Sun Yat-sen University, China. Cells 
were maintained in RPMI-1640 supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 
100 mg/mL  streptomycin  sulfate  at  37  °C ,  5%  CO2.The  MTT  assay  was  performed  as  described 
previously  [10].  The  IC50  values  were  calculated  by  SPSS  software  with  Probit  model.  The 
morphological  changes  were  observed  under  an  inverted  microscope  at  different  magnifications. 
Photos were taken after 24 h of drug treatment before MTT dyeing.  Mar. Drugs 2011, 9  
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